Protein NMB0928 and use thereof in pharmaceutical formulations

Details for Australian Patent Application No. 2004294377 (hide)

Owner Centro de Ingenieria Genetica y Biotecnologia

Inventors Guillen Nieto, Gerardo Enrique; Betancourt Nunez, Lazaro Hiram; Castellanos Serra, Lila Rosa; Garcia Diaz, Darien; Caballero Menendez, Evelin; Sardinas Garcia, Gretel; Niebla Perez, Olivia; Perera Negrin, Yasser; Pajon Feyt, Rolando; Gonzalez Blanco, Sonia

Agent Shelston IP

Pub. Number AU-A-2004294377

PCT Pub. Number WO2005/054282

Priority CU2003/0286 03.12.03 CU

Filing date 2 December 2004

Wipo publication date 16 June 2005

International Classifications

C07K 14/22 (2006.01) Peptides having more than 20 amino acids

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/054282 Priority application(s): WO2005/054282

30 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294403-Nanofiltration of factor VII solutions to remove virus

2004294376-Protein NMB1125 and use thereof in pharmaceutical formulations